{"pmid":32343223,"title":"Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.","text":["Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.","Invasive pulmonary aspergillosis is a complication in critically ill patients with acute respiratory distress syndrome, especially those with severe influenza pneumonia. We report a fatal case of invasive pulmonary aspergillosis in an immunocompetent patient in France who had severe coronavirus disease-associated pneumonia.","Emerg Infect Dis","Blaize, Marion","Mayaux, Julien","Nabet, Cecile","Lampros, Alexandre","Marcelin, Anne-Genevieve","Thellier, Marc","Piarroux, Renaud","Demoule, Alexandre","Fekkar, Arnaud","32343223"],"abstract":["Invasive pulmonary aspergillosis is a complication in critically ill patients with acute respiratory distress syndrome, especially those with severe influenza pneumonia. We report a fatal case of invasive pulmonary aspergillosis in an immunocompetent patient in France who had severe coronavirus disease-associated pneumonia."],"journal":"Emerg Infect Dis","authors":["Blaize, Marion","Mayaux, Julien","Nabet, Cecile","Lampros, Alexandre","Marcelin, Anne-Genevieve","Thellier, Marc","Piarroux, Renaud","Demoule, Alexandre","Fekkar, Arnaud"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32343223","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3201/eid2607.201603","keywords":["aspergillus","covid-19","sars","sars-cov-2","aspergillosis","coronavirus","coronavirus disease","fungal superinfection","fungi","intensive care unit","mechanical ventilation","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Case Report"],"weight":1,"_version_":1666138495068930048,"score":9.490897,"similar":[{"pmid":32339350,"title":"COVID-19 Associated Pulmonary Aspergillosis.","text":["COVID-19 Associated Pulmonary Aspergillosis.","OBJECTIVES: Patients with acute respiratory distress syndrome (ARDS) due to viral infection are at risk for secondary complications like invasive aspergillosis. Our study evaluates Coronavirus disease 19 (COVID-19) associated invasive aspergillosis at a single center in Cologne, Germany. METHODS: A retrospective chart review of all patients with COVID-19 ARDS admitted to the medical or surgical intensive care unit at the University Hospital of Cologne, Germany. RESULTS: COVID-19 associated invasive pulmonary aspergillosis was found in five of 19 consecutive critically ill patients with moderate to severe ARDS. CONCLUSION: Clinicians caring for patients with ARDS due to COVID-19 should consider invasive pulmonary aspergillosis and subject respiratory samples to comprehensive analysis to detect co-infection.","Mycoses","Koehler, Philipp","Cornely, Oliver A","Bottiger, Bernd W","Dusse, Fabian","Eichenauer, Dennis A","Fuchs, Frieder","Hallek, Michael","Jung, Norma","Klein, Florian","Persigehl, Thorsten","Rybniker, Jan","Kochanek, Matthias","Boll, Boris","Shimabukuro-Vornhagen, Alexander","32339350"],"abstract":["OBJECTIVES: Patients with acute respiratory distress syndrome (ARDS) due to viral infection are at risk for secondary complications like invasive aspergillosis. Our study evaluates Coronavirus disease 19 (COVID-19) associated invasive aspergillosis at a single center in Cologne, Germany. METHODS: A retrospective chart review of all patients with COVID-19 ARDS admitted to the medical or surgical intensive care unit at the University Hospital of Cologne, Germany. RESULTS: COVID-19 associated invasive pulmonary aspergillosis was found in five of 19 consecutive critically ill patients with moderate to severe ARDS. CONCLUSION: Clinicians caring for patients with ARDS due to COVID-19 should consider invasive pulmonary aspergillosis and subject respiratory samples to comprehensive analysis to detect co-infection."],"journal":"Mycoses","authors":["Koehler, Philipp","Cornely, Oliver A","Bottiger, Bernd W","Dusse, Fabian","Eichenauer, Dennis A","Fuchs, Frieder","Hallek, Michael","Jung, Norma","Klein, Florian","Persigehl, Thorsten","Rybniker, Jan","Kochanek, Matthias","Boll, Boris","Shimabukuro-Vornhagen, Alexander"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339350","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/myc.13096","keywords":["aspergillus","ecmo","icu","sars-cov-2","isavuconazole","voriconazole"],"locations":["Cologne","Germany","Germany"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"topics":["Treatment"],"weight":1,"_version_":1666138494201757698,"score":300.7206},{"pmid":32395423,"pmcid":"PMC7211620","title":"Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report.","text":["Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report.","It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), who developed IPA two weeks after onset of symptoms. Our report shows that IPA may occur in critically ill COVID-19 patients.","Med Mycol Case Rep","Prattes, Juergen","Valentin, Thomas","Hoenigl, Martin","Talakic, Emina","Reisinger, Alexander C","Eller, Philipp","32395423"],"abstract":["It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), who developed IPA two weeks after onset of symptoms. Our report shows that IPA may occur in critically ill COVID-19 patients."],"journal":"Med Mycol Case Rep","authors":["Prattes, Juergen","Valentin, Thomas","Hoenigl, Martin","Talakic, Emina","Reisinger, Alexander C","Eller, Philipp"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32395423","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.mmcr.2020.05.001","keywords":["aspergillosis","covid-19","icu"],"topics":["Case Report"],"weight":1,"_version_":1666627827935477760,"score":271.60382},{"pmid":32487793,"title":"Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.","text":["Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.","Invasive pulmonary aspergillosis (IPA) is a life-threatening condition that usually occurs in immunocompromised hosts. However, according to recent reports it can affect immunocompetent hosts with severe influenza infection due to viral-dependent disruption of respiratory immune defenses. We present the case of a 61-year-old Caucasian man admitted to the Emergency Department with respiratory failure and fever, who was diagnosed with H1N1 influenza and IPA. Because of his poor general conditions, he was treated with a double antifungal scheme, although this lies outside the suggested treatment guidelines. This choice turned out to be extremely effective. He was discharged after one month and his clinical conditions showed rapid improvement, with nearly complete normalization of the radiological pattern in three months. IPA remains a life-threatening condition, even in immunocompetent hosts, and should therefore always be suspected; if necessary, a combined treatment should rapidly be started. We report this case as the interest in influenza-associated IPA is high, both due to the clinical severity of this condition, which is treatable if identified early, and the emerging importance of respiratory infections caused by viruses belonging to the SARS family, such as SARS-CoV-2.","Infez Med","Saccaro, Luigi Francesco","Galfo, Valentina","Ferranti, Simone","Russo, Alessandro","Menichetti, Francesco","32487793"],"abstract":["Invasive pulmonary aspergillosis (IPA) is a life-threatening condition that usually occurs in immunocompromised hosts. However, according to recent reports it can affect immunocompetent hosts with severe influenza infection due to viral-dependent disruption of respiratory immune defenses. We present the case of a 61-year-old Caucasian man admitted to the Emergency Department with respiratory failure and fever, who was diagnosed with H1N1 influenza and IPA. Because of his poor general conditions, he was treated with a double antifungal scheme, although this lies outside the suggested treatment guidelines. This choice turned out to be extremely effective. He was discharged after one month and his clinical conditions showed rapid improvement, with nearly complete normalization of the radiological pattern in three months. IPA remains a life-threatening condition, even in immunocompetent hosts, and should therefore always be suspected; if necessary, a combined treatment should rapidly be started. We report this case as the interest in influenza-associated IPA is high, both due to the clinical severity of this condition, which is treatable if identified early, and the emerging importance of respiratory infections caused by viruses belonging to the SARS family, such as SARS-CoV-2."],"journal":"Infez Med","authors":["Saccaro, Luigi Francesco","Galfo, Valentina","Ferranti, Simone","Russo, Alessandro","Menichetti, Francesco"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32487793","source":"PubMed","week":"202023|Jun 01 - Jun 07","locations":["Caucasian"],"topics":["Case Report"],"weight":1,"_version_":1668623433744777216,"score":253.28958},{"pmid":32437316,"title":"Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States.","text":["Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States.","An ongoing pandemic of coronavirus disease (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Characterization of the histopathology and cellular localization of SARS-CoV-2 in the tissues of patients with fatal COVID-19 is critical to further understand its pathogenesis and transmission and for public health prevention measures. We report clinicopathologic, immunohistochemical, and electron microscopic findings in tissues from 8 fatal laboratory-confirmed cases of SARS-CoV-2 infection in the United States. All cases except 1 were in residents of long-term care facilities. In these patients, SARS-CoV-2 infected epithelium of the upper and lower airways with diffuse alveolar damage as the predominant pulmonary pathology. SARS-CoV-2 was detectable by immunohistochemistry and electron microscopy in conducting airways, pneumocytes, alveolar macrophages, and a hilar lymph node but was not identified in other extrapulmonary tissues. Respiratory viral co-infections were identified in 3 cases; 3 cases had evidence of bacterial co-infection.","Emerg Infect Dis","Martines, Roosecelis B","Ritter, Jana M","Matkovic, Eduard","Gary, Joy","Bollweg, Brigid C","Bullock, Hannah","Goldsmith, Cynthia S","Silva-Flannery, Luciana","Seixas, Josilene N","Reagan-Steiner, Sarah","Uyeki, Timothy","Denison, Amy","Bhatnagar, Julu","Shieh, Wun-Ju","Zaki, Sherif R","32437316"],"abstract":["An ongoing pandemic of coronavirus disease (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Characterization of the histopathology and cellular localization of SARS-CoV-2 in the tissues of patients with fatal COVID-19 is critical to further understand its pathogenesis and transmission and for public health prevention measures. We report clinicopathologic, immunohistochemical, and electron microscopic findings in tissues from 8 fatal laboratory-confirmed cases of SARS-CoV-2 infection in the United States. All cases except 1 were in residents of long-term care facilities. In these patients, SARS-CoV-2 infected epithelium of the upper and lower airways with diffuse alveolar damage as the predominant pulmonary pathology. SARS-CoV-2 was detectable by immunohistochemistry and electron microscopy in conducting airways, pneumocytes, alveolar macrophages, and a hilar lymph node but was not identified in other extrapulmonary tissues. Respiratory viral co-infections were identified in 3 cases; 3 cases had evidence of bacterial co-infection."],"journal":"Emerg Infect Dis","authors":["Martines, Roosecelis B","Ritter, Jana M","Matkovic, Eduard","Gary, Joy","Bollweg, Brigid C","Bullock, Hannah","Goldsmith, Cynthia S","Silva-Flannery, Luciana","Seixas, Josilene N","Reagan-Steiner, Sarah","Uyeki, Timothy","Denison, Amy","Bhatnagar, Julu","Shieh, Wun-Ju","Zaki, Sherif R"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437316","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3201/eid2609.202095","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","coronavirus","coronavirus disease","diffuse alveolar damage","electron microscopy","histopathology","immunohistochemistry","pathology","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["United States","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1667521393565106176,"score":145.53294},{"pmid":32315282,"title":"Estimation of Coronavirus Disease Case-Fatality Risk in Real Time.","text":["Estimation of Coronavirus Disease Case-Fatality Risk in Real Time.","We ran a simulation comparing 3 methods to calculate case-fatality risk for coronavirus disease using parameters described in previous studies. Case-fatality risk calculated from these methods all are biased at the early stage of the epidemic. When comparing real-time case-fatality risk, the current trajectory of the epidemic should be considered.","Emerg Infect Dis","Ge, Yang","Sun, Shengzhi","32315282"],"abstract":["We ran a simulation comparing 3 methods to calculate case-fatality risk for coronavirus disease using parameters described in previous studies. Case-fatality risk calculated from these methods all are biased at the early stage of the epidemic. When comparing real-time case-fatality risk, the current trajectory of the epidemic should be considered."],"journal":"Emerg Infect Dis","authors":["Ge, Yang","Sun, Shengzhi"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315282","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.201096","keywords":["2019 novel coronavirus disease","covid-19","sars","sars-cov-2","coronavirus","coronavirus disease","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138493569466368,"score":136.07466}]}